FASLG and pancreatic adenocarcinoma: A previous report demonstrated that DcR3 knockdown with FasL treatment significantly suppressed cell proliferation in human pancreatic adenocarcinoma cells (38), therefore, we evaluated the effect of DcR3 inhibition with FasL treatment on MFH cell proliferation.